These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 348087)

  • 1. Phase I and II studies with hexitol derivatives, formyl-leurosine and ftorafur.
    Eckhardt S
    Antibiot Chemother (1971); 1978; 23():50-7. PubMed ID: 348087
    [No Abstract]   [Full Text] [Related]  

  • 2. 1,2:5,6-Dianhydrogalactitol in advanced breast cancer.
    Hoogstraten B; O'Bryan R; Jones S
    Cancer Treat Rep; 1978 May; 62(5):841-2. PubMed ID: 657167
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.
    Ahmann DL; O'Connell MJ; Bisel HF; Edmonson JH; Hahn RG; Frytak S
    Cancer Treat Rep; 1977; 61(1):81-2. PubMed ID: 324622
    [No Abstract]   [Full Text] [Related]  

  • 4. [New substances in oncologic therapy].
    Cavalli F; Brunner KW
    Dtsch Med Wochenschr; 1978 Jul; 103(27):1087-92. PubMed ID: 78789
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of dibromo-dulcitol, diepoxy dulcitol and various new cytostatic hexitol derivatives on the metabolic activities of nucleic acids and proteins--II.
    Hidvégi EJ; Sebestyén J; Szabó LD; Köteles GJ; Institoris L
    Biochem Pharmacol; 1976 Aug; 25(15):1705-10. PubMed ID: 942473
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.
    Perry MC; Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Treat Rep; 1976 Sep; 60(9):1247-50. PubMed ID: 797447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
    Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticancer chemotherapy.
    Davey P; Tudhope GR
    Br Med J (Clin Res Ed); 1983 Jul; 287(6385):110-3. PubMed ID: 6407699
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcoma.
    Fuzy M; Lelieveld P; Van Putten LM
    Eur J Cancer (1965); 1975 Mar; 11(3):169-73. PubMed ID: 165939
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neurotoxicity of formyl leurosine. An experimental and clinical study (author's transl)].
    Hildebrand J; Joffroy A; Vauthier J; Flamant-Durand J
    Acta Neurol Belg; 1979; 79(4):322-34. PubMed ID: 232962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of dianhydrogalactitol administered Iv in a weekly schedule.
    Vogel CL; Winton EF; Moore MR; Sohner S
    Cancer Treat Rep; 1976 Jul; 60(7):895-901. PubMed ID: 795538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I evaluation of dianhydrogalactitol (NSC-132313).
    Haas CD; Stephens RL; Hollister M; Hoogstraten B
    Cancer Treat Rep; 1976 May; 60(5):611-4. PubMed ID: 991150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [10 years of using ftorafur in antitumor chemotherapy].
    Tannenberger S; Müller U
    Farmakol Toksikol; 1986; 49(6):77-9. PubMed ID: 3102278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of mitolactol in squamous cell carcinoma of the head and neck: a Southeastern Cancer Study Group Trial.
    McHale MS; Velez-Garcia E; Nelson O; Williams SD; Maddox W; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):925-6. PubMed ID: 3521849
    [No Abstract]   [Full Text] [Related]  

  • 15. New vinca alkaloids and related compounds.
    Budman DR
    Semin Oncol; 1992 Dec; 19(6):639-45. PubMed ID: 1462165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomas.
    Mischler NE; Tormey DC; Klotz J; Borden EC; Ramirez G; Banerjee TK; Carr RM; Zaentz SD; Graf J
    Cancer Clin Trials; 1981; 4(4):407-10. PubMed ID: 7318122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
    Miller TP; Jones SE; Chester AB; Dorr RT
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
    Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK
    Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between lymphotropic cytostatic treatment and lymphocytic choriomeningitis virus infection in mice.
    Szeri I; Alföldy Z; Anderlik P; Bános Z; Radnai B
    Ann Immunol Hung; 1972; 16(0):445-51. PubMed ID: 4679684
    [No Abstract]   [Full Text] [Related]  

  • 20. Five-day schedule of vinzolidine, an oral vinca alkaloid, in a variety of tumors.
    Takasugi BJ; Robertone AB; Salmon SE; Jones SE; Alberts DS
    Invest New Drugs; 1984; 2(4):387-90. PubMed ID: 6096287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.